Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Drug Discovery Automation: High-content Screening & Cell Based Assays

Emma Shanks's Biography



Emma Shanks, Head of Screening, Beatson Institute for Cancer Research

After completing a PhD at the University of Dundee, I worked in the newly established Drug Discovery Unit in Dundee, developing assays for biochemical and phenotypic screens to support high throughput siRNA and small molecule screens; this work aimed to find new therapies for neglected tropical diseases and novel targets for diseases such as cancer. I currently run a cancer research focused Screening Facility which aims to identify novel drug targets in key pathways and mechanisms, reduce chemotherapeutic drug resistance and side effects, and identify new therapeutics from existing non-cancer drugs. Our own research centres on drug repurposing approaches and identifying novel therapeutics for Head and Neck Squamous Cell Carcinoma (HNSCC)

Emma Shanks Image

siRNAs, Small Molecules and Drug Repurposing: Combined Screening Approaches to Targeting Cancer

Friday, 7 June 2013 at 09:15

Add to Calendar ▼2013-06-07 09:15:002013-06-07 10:15:00Europe/LondonsiRNAs, Small Molecules and Drug Repurposing: Combined Screening Approaches to Targeting Cancer SELECTBIOenquiries@selectbiosciences.com

Our combination approach using siRNA libraries with small molecule High Content screening has elucidated putative novel players across multiple cancer backgrounds. Moreover, our work with drug repurposing adds breadth to our hit deconvolution and elucidation of potential novel therapeutic combinations.


Add to Calendar ▼2013-06-06 00:00:002013-06-07 00:00:00Europe/LondonDrug Discovery Automation: High-content Screening and Cell Based AssaysSELECTBIOenquiries@selectbiosciences.com